Apotea (APOTEA) — Cash Flow Reinvestment Rate
Latest as of March 2026:
0.02x
Apotea (APOTEA) has a Cash Flow Reinvestment Rate of 0.02x as of March 2026, reinvesting Skr1.70 Million (capex Skr1.70 Million ) from operating cash flow of Skr112.50 Million. Check earnings quality score of Apotea to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.02x
(Capex + Investments) / Operating CF
Total Reinvested
Skr1.70 Million
Capex + Investments
Operating Cash Flow
Skr112.50 Million
SEK
Capital Expenditures
Skr1.70 Million
SEK
Apotea Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Apotea across 4 annual periods. Explore how well can Apotea service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Apotea (2022–2025)
Year-by-year capital reinvestment analysis for Apotea. For live market cap and broader valuation context, see Apotea (APOTEA) total market value.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.65x | Skr215.60 Million | Skr333.30 Million | Skr215.60 Million | ▼ -18.6% |
| 2024 | 0.79x | Skr163.90 Million | Skr206.20 Million | Skr163.80 Million | ▲ +40.9% |
| 2023 | 0.56x | Skr121.70 Million | Skr215.80 Million | Skr121.10 Million | ▼ -88.1% |
| 2022 | 4.73x | Skr149.10 Million | Skr31.50 Million | Skr142.10 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow